New Investigator Awards

2020 New Investigator Award Applications (closed)


The ASTCT New Investigator Award in designed to encourage clinical or laboratory research by young investigators in the BMT field. The award is $30,000 per year, typically for two years, and is preferably to be used to support the investigator’s salary for his or her research effort. Alternatively, the award may be used for direct support of research costs.


  • To be eligible for consideration for a New Investigator Award, the applicant must be a physician (M.D., D.O., or international equivalent) or hold a Ph.D. or international equivalent. 
  • By the award start date of July 1, 2020, the applicant must have completed at least two years of postdoctoral training.  For applicants who are full-time junior faculty (Instructor, Asst. Professor, or equivalent) at an academic institution, that appointment or promotion must have occurred on, or after, July 1, 2017 (i.e., no more than three years before the award start date of July 1, 2020).
  • Grant applications from candidates with existing career development awards (such as K23, K08, Leukemia & Lymphoma Society Fellow/Special Fellow or any others of this type) will not be considered, nor will applications from candidates with independent, nonmentored peer-reviewed funding (such as R01, P01 or comparable). Institutional startup funds for junior faculty are not considered peer-reviewed or extramural.
  • An applicant may submit only one application per cycle. Applicants with other funding that overlaps an approved application’s scope of work must choose one or the other; they may not keep both. This applies up to and through the duration of the funded project.
  • Applicants are encouraged, but not required, to be ASTCT members. An applicant must have a sponsor who is an ASTCT member. This sponsor serves as a mentor for the applicant’s research and career development.


Applicants are required to submit the New Investigator Award application, a curriculum vitae that adheres to the NIH Biographical Sketch format, a list of other support that also adheres to the NIH format, a letter of recommendation from the applicant's sponsor/mentor (two pages maximum) and a description of the proposed research (five pages maximum).

Judging and Evaluation Criteria

Submitted applications will be reviewed by the standing study section. The study section is chaired by a member of ASTCT, appointed by the ASTCT President with Board approval. As needed, the chair can appoint ad hoc reviewers based on specific expertise required to review the topics covered by the submitted applications.

Applications are especially encouraged in the following areas of interest to ASTCT:

  1. clinical stem cell transplantation and other immune cell therapies
  2. conditioning regimens
  3. health services research in transplant and cell therapy (includes survivorship and patient-reported outcomes, quality improvement studies, secondary analyses of large datasets, cost-effectiveness analyses, etc.)
  4. infectious prophylaxis and/or infectious complications of transplant
  5. preclinical models of transplant
  6. stem cell biology
  7. transplantation immunology, incl but not limited to GvHD and GvT/GvM/GvL

New Investigator Award applications will be evaluated for:

  • Scientific merit within the BMT field
  • Significance and anticipated overall impact of the potential findings to the BMT field
  • Institutional environment
  • Training record of the sponsor/mentor

As these are “new” investigator awards, less emphasis is placed on preliminary data.

ASTCT is committed to awarding at least 5 awards annually. 

Due to the additional work that would be required of reviewers and the short timelines involved, applicants will not receive written critiques after review.


Award winner(s) will be notified in mid-December, 2019, in time to make arrangements to attend the Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, where the award(s) will be publicly announced. The award(s) will be activated in July, 2020.


The award is $30,000 and is renewable for a second year, contingent on a report of satisfactory progress and continued funding by the award sponsor. That report must be submitted to the ASTCT executive office no later than June 1, 2020.

Please submit your application on or before Monday, September 9, 2019 to ASTCT Headquarters.

Past ASTCT New Investigator Awards have been made possible with the generous support of the following:

  • Jazz Pharmaceuticals
  • Gabrielle's Angel Foundation for Cancer Research
  • Merck
  • Sarah Cannon
  • Takeda
  • Celgene
  • Amgen
  • Sanofi Genzyme
  • Pharmacyclics / Janssen